We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)

Video   Jun 23, 2015

 

In collaboration with research groups and the Hospital District of Helsinki and Uusimaa, we have set up drug sensitivity and resistance testing (DSRT) platform with a set of 461 approved and investigational oncology drugs on patient samples. Ex vivo drug testing is currently performed at FIMM with primary cancer cells from patients with leukemia and multiple myeloma as well as cancer cell lines. The drug sensitivity responses, measured by cell viability and death readouts, are integrated with molecular profiling such as exome sequencing, transcriptomics and phosphoproteomics. Application of the platform to AML patient samples has uncovered taxonomic drug-response subtypes and individualised therapy based on DSRT has resulted in several clinical responses. The DSRT platform enables drug repositioning, provides new combinatorial possibilities and allows for linking drug sensitivities to predictive biomarkers. We are developing the platform with additional readouts and increasing the number of drugs. Our Labcyte Access Workstation, with Echo550 and Echo525 integration, allows development and set-up of miniaturised follow-up assays, such as reverse-phase protein array and qPCR, using non-contact acoustic dispensing.

 
 
 
 

Recommended Videos

Incredible DNA Animations

Video

Check out the action going on inside a cell's nucleus.

WATCH NOW

Operetta CLS High-Content Analysis System

Video

The Operetta CLS system is part of PerkinElmer's comprehensive HCS portfolio – from HCS systems and microplates to automation and informatics.

WATCH NOW

Genetic Causes of Myeloma

Video

Myeloma occurs as a result of changes in the genetic material within plasma cells. This animation explains what happens at the genetic level which causes myeloma to develop.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE